$ACRS Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Aclaris Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Aclaris Therapeutics, Inc.. Get notifications about new insider transactions in Aclaris Therapeutics, Inc. for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 07 2021 | ACRS | Aclaris Therapeuti ... | Ali-Jackson Kamil | Chief Legal Officer | Option Exercise | M | 10.66 | 5,416 | 57,735 | 0 | |
| May 07 2021 | ACRS | Aclaris Therapeuti ... | Ali-Jackson Kamil | Chief Legal Officer | Option Exercise | M | 10.66 | 15,000 | 159,900 | 5,416 | |
| May 07 2021 | ACRS | Aclaris Therapeuti ... | Ali-Jackson Kamil | Chief Legal Officer | Sell | S | 23.99 | 2,100 | 50,376 | 143,618 | 145.7 K to 143.6 K (-1.44 %) |
| May 07 2021 | ACRS | Aclaris Therapeuti ... | Ali-Jackson Kamil | Chief Legal Officer | Sell | S | 23.23 | 3,316 | 77,016 | 145,718 | 149 K to 145.7 K (-2.22 %) |
| May 07 2021 | ACRS | Aclaris Therapeuti ... | Ali-Jackson Kamil | Chief Legal Officer | Buy | M | 10.66 | 5,416 | 57,735 | 149,034 | 143.6 K to 149 K (+3.77 %) |
| May 07 2021 | ACRS | Aclaris Therapeuti ... | Ali-Jackson Kamil | Chief Legal Officer | Sell | S | 23.86 | 3,102 | 74,016 | 143,618 | 146.7 K to 143.6 K (-2.11 %) |
| May 07 2021 | ACRS | Aclaris Therapeuti ... | Ali-Jackson Kamil | Chief Legal Officer | Sell | S | 23.32 | 11,898 | 277,438 | 146,720 | 158.6 K to 146.7 K (-7.50 %) |
| May 07 2021 | ACRS | Aclaris Therapeuti ... | Ali-Jackson Kamil | Chief Legal Officer | Buy | M | 10.66 | 15,000 | 159,900 | 158,618 | 143.6 K to 158.6 K (+10.44 %) |
| May 05 2021 | ACRS | Aclaris Therapeuti ... | Ali-Jackson Kamil | Chief Legal Officer | Option Exercise | M | 10.66 | 15,000 | 159,900 | 20,416 | |
| May 05 2021 | ACRS | Aclaris Therapeuti ... | Ali-Jackson Kamil | Chief Legal Officer | Option Exercise | M | 10.66 | 15,000 | 159,900 | 35,416 | |
| May 05 2021 | ACRS | Aclaris Therapeuti ... | Ali-Jackson Kamil | Chief Legal Officer | Option Exercise | M | 10.66 | 15,000 | 159,900 | 50,416 | |
| May 05 2021 | ACRS | Aclaris Therapeuti ... | Ali-Jackson Kamil | Chief Legal Officer | Sell | S | 24.36 | 498 | 12,129 | 143,618 | 144.1 K to 143.6 K (-0.35 %) |
| May 05 2021 | ACRS | Aclaris Therapeuti ... | Ali-Jackson Kamil | Chief Legal Officer | Sell | S | 23.97 | 14,502 | 347,584 | 144,116 | 158.6 K to 144.1 K (-9.14 %) |
| May 05 2021 | ACRS | Aclaris Therapeuti ... | Ali-Jackson Kamil | Chief Legal Officer | Buy | M | 10.66 | 15,000 | 159,900 | 158,618 | 143.6 K to 158.6 K (+10.44 %) |
| May 05 2021 | ACRS | Aclaris Therapeuti ... | Ali-Jackson Kamil | Chief Legal Officer | Sell | S | 24.47 | 1,279 | 31,296 | 143,618 | 144.9 K to 143.6 K (-0.88 %) |
| May 05 2021 | ACRS | Aclaris Therapeuti ... | Ali-Jackson Kamil | Chief Legal Officer | Sell | S | 23.61 | 13,721 | 323,891 | 144,897 | 158.6 K to 144.9 K (-8.65 %) |
| May 05 2021 | ACRS | Aclaris Therapeuti ... | Ali-Jackson Kamil | Chief Legal Officer | Buy | M | 10.66 | 15,000 | 159,900 | 158,618 | 143.6 K to 158.6 K (+10.44 %) |
| May 05 2021 | ACRS | Aclaris Therapeuti ... | Ali-Jackson Kamil | Chief Legal Officer | Sell | S | 24.91 | 4,339 | 108,074 | 143,618 | 148 K to 143.6 K (-2.93 %) |
| May 05 2021 | ACRS | Aclaris Therapeuti ... | Ali-Jackson Kamil | Chief Legal Officer | Sell | S | 24.46 | 10,661 | 260,745 | 147,957 | 158.6 K to 148 K (-6.72 %) |
| May 05 2021 | ACRS | Aclaris Therapeuti ... | Ali-Jackson Kamil | Chief Legal Officer | Buy | M | 10.66 | 15,000 | 159,900 | 158,618 | 143.6 K to 158.6 K (+10.44 %) |
| Apr 26 2021 | ACRS | Aclaris Therapeuti ... | Ruffo Frank | Chief Financial Off ... | Sell | S | 26.44 | 100 | 2,644 | 151,720 | 151.8 K to 151.7 K (-0.07 %) |
| Apr 26 2021 | ACRS | Aclaris Therapeuti ... | Ruffo Frank | Chief Financial Off ... | Sell | S | 26.44 | 100 | 2,644 | 151,720 | 151.8 K to 151.7 K (-0.07 %) |
| Apr 26 2021 | ACRS | Aclaris Therapeuti ... | Ruffo Frank | Chief Financial Off ... | Sell | S | 25.79 | 27,239 | 702,584 | 151,820 | 179.1 K to 151.8 K (-15.21 %) |
| Apr 26 2021 | ACRS | Aclaris Therapeuti ... | Ruffo Frank | Chief Financial Off ... | Sell | S | 25.79 | 27,239 | 702,584 | 151,820 | 179.1 K to 151.8 K (-15.21 %) |
| Apr 26 2021 | ACRS | Aclaris Therapeuti ... | Ruffo Frank | Chief Financial Off ... | Sell | S | 27.33 | 800 | 21,863 | 179,059 | 179.9 K to 179.1 K (-0.44 %) |
| Apr 26 2021 | ACRS | Aclaris Therapeuti ... | Ruffo Frank | Chief Financial Off ... | Sell | S | 27.33 | 800 | 21,863 | 179,059 | 179.9 K to 179.1 K (-0.44 %) |
| Apr 26 2021 | ACRS | Aclaris Therapeuti ... | Ruffo Frank | Chief Financial Off ... | Sell | S | 26.64 | 29,200 | 777,797 | 179,859 | 209.1 K to 179.9 K (-13.97 %) |
| Apr 26 2021 | ACRS | Aclaris Therapeuti ... | Ruffo Frank | Chief Financial Off ... | Sell | S | 26.64 | 29,200 | 777,797 | 179,859 | 209.1 K to 179.9 K (-13.97 %) |
| Apr 26 2021 | ACRS | Aclaris Therapeuti ... | Ruffo Frank | Chief Financial Off ... | Sell | S | 26.84 | 30,000 | 805,218 | 209,059 | 239.1 K to 209.1 K (-12.55 %) |
| Apr 26 2021 | ACRS | Aclaris Therapeuti ... | Ruffo Frank | Chief Financial Off ... | Sell | S | 26.84 | 30,000 | 805,218 | 209,059 | 239.1 K to 209.1 K (-12.55 %) |
| Apr 26 2021 | ACRS | Aclaris Therapeuti ... | Walker Neal | President and CEO | Sell | S | 26.84 | 30,000 | 805,239 | 1,192,427 | 1.2 M to 1.2 M (-2.45 %) |
| Apr 26 2021 | ACRS | Aclaris Therapeuti ... | Walker Neal | President and CEO | Sell | S | 26.84 | 30,000 | 805,239 | 1,192,427 | 1.2 M to 1.2 M (-2.45 %) |
| Mar 03 2021 | ACRS | Aclaris Therapeuti ... | Gordon David N. | Chief Medical Offic ... | Option Exercise | M | 0.00 | 8,297 | 0 | 24,892 | |
| Mar 03 2021 | ACRS | Aclaris Therapeuti ... | Gordon David N. | Chief Medical Offic ... | Option Exercise | M | 0.00 | 20,600 | 0 | 41,200 | |
| Mar 03 2021 | ACRS | Aclaris Therapeuti ... | Gordon David N. | Chief Medical Offic ... | Option Exercise | A | 0.00 | 28,400 | 0 | 28,400 | |
| Mar 03 2021 | ACRS | Aclaris Therapeuti ... | Gordon David N. | Chief Medical Offic ... | Option Exercise | A | 24.06 | 99,500 | 2,393,970 | 99,500 | |
| Mar 03 2021 | ACRS | Aclaris Therapeuti ... | Gordon David N. | Chief Medical Offic ... | Payment of Exercise | F | 23.25 | 2,280 | 53,010 | 108,492 | 110.8 K to 108.5 K (-2.06 %) |
| Mar 03 2021 | ACRS | Aclaris Therapeuti ... | Gordon David N. | Chief Medical Offic ... | Buy | M | 0.00 | 8,297 | 0 | 110,772 | 102.5 K to 110.8 K (+8.10 %) |
| Mar 03 2021 | ACRS | Aclaris Therapeuti ... | Gordon David N. | Chief Medical Offic ... | Payment of Exercise | F | 24.06 | 5,660 | 136,180 | 102,475 | 108.1 K to 102.5 K (-5.23 %) |
| Mar 03 2021 | ACRS | Aclaris Therapeuti ... | Gordon David N. | Chief Medical Offic ... | Buy | M | 0.00 | 20,600 | 0 | 108,135 | 87.5 K to 108.1 K (+23.53 %) |
| Mar 03 2021 | ACRS | Aclaris Therapeuti ... | Ali-Jackson Kamil | Chief Legal Officer | Option Exercise | M | 0.00 | 6,637 | 0 | 19,914 | |
| Mar 03 2021 | ACRS | Aclaris Therapeuti ... | Ali-Jackson Kamil | Chief Legal Officer | Option Exercise | M | 0.00 | 17,175 | 0 | 34,350 | |
| Mar 03 2021 | ACRS | Aclaris Therapeuti ... | Ali-Jackson Kamil | Chief Legal Officer | Option Exercise | A | 0.00 | 28,400 | 0 | 28,400 | |
| Mar 03 2021 | ACRS | Aclaris Therapeuti ... | Ali-Jackson Kamil | Chief Legal Officer | Option Exercise | A | 24.06 | 99,500 | 2,393,970 | 99,500 | |
| Mar 03 2021 | ACRS | Aclaris Therapeuti ... | Ali-Jackson Kamil | Chief Legal Officer | Payment of Exercise | F | 23.25 | 1,906 | 44,315 | 143,618 | 145.5 K to 143.6 K (-1.31 %) |
| Mar 03 2021 | ACRS | Aclaris Therapeuti ... | Ali-Jackson Kamil | Chief Legal Officer | Buy | M | 0.00 | 6,637 | 0 | 145,524 | 138.9 K to 145.5 K (+4.78 %) |
| Mar 03 2021 | ACRS | Aclaris Therapeuti ... | Ali-Jackson Kamil | Chief Legal Officer | Payment of Exercise | F | 24.06 | 4,934 | 118,712 | 138,887 | 143.8 K to 138.9 K (-3.43 %) |
| Mar 03 2021 | ACRS | Aclaris Therapeuti ... | Ali-Jackson Kamil | Chief Legal Officer | Buy | M | 0.00 | 17,175 | 0 | 143,821 | 126.6 K to 143.8 K (+13.56 %) |
| Mar 03 2021 | ACRS | Aclaris Therapeuti ... | Ruffo Frank | Chief Financial Off ... | Option Exercise | M | 0.00 | 8,297 | 0 | 24,892 | |
| Mar 03 2021 | ACRS | Aclaris Therapeuti ... | Ruffo Frank | Chief Financial Off ... | Option Exercise | M | 0.00 | 25,750 | 0 | 51,500 | |
| Mar 03 2021 | ACRS | Aclaris Therapeuti ... | Ruffo Frank | Chief Financial Off ... | Option Exercise | A | 0.00 | 33,200 | 0 | 33,200 | |
| Mar 03 2021 | ACRS | Aclaris Therapeuti ... | Ruffo Frank | Chief Financial Off ... | Option Exercise | A | 24.06 | 116,000 | 2,790,960 | 116,000 | |
| Mar 03 2021 | ACRS | Aclaris Therapeuti ... | Ruffo Frank | Chief Financial Off ... | Payment of Exercise | F | 23.25 | 2,844 | 66,123 | 239,059 | 241.9 K to 239.1 K (-1.18 %) |
| Mar 03 2021 | ACRS | Aclaris Therapeuti ... | Ruffo Frank | Chief Financial Off ... | Buy | M | 0.00 | 8,297 | 0 | 241,903 | 233.6 K to 241.9 K (+3.55 %) |
| Mar 03 2021 | ACRS | Aclaris Therapeuti ... | Ruffo Frank | Chief Financial Off ... | Payment of Exercise | F | 24.06 | 7,333 | 176,432 | 233,606 | 240.9 K to 233.6 K (-3.04 %) |
| Mar 03 2021 | ACRS | Aclaris Therapeuti ... | Ruffo Frank | Chief Financial Off ... | Buy | M | 0.00 | 25,750 | 0 | 240,939 | 215.2 K to 240.9 K (+11.97 %) |
| Mar 03 2021 | ACRS | Aclaris Therapeuti ... | Walker Neal | President and CEO | Option Exercise | M | 0.00 | 18,253 | 0 | 54,762 | |
| Mar 03 2021 | ACRS | Aclaris Therapeuti ... | Walker Neal | President and CEO | Option Exercise | M | 0.00 | 96,150 | 0 | 192,300 | |
| Mar 03 2021 | ACRS | Aclaris Therapeuti ... | Walker Neal | President and CEO | Option Exercise | A | 0.00 | 73,100 | 0 | 73,100 | |
| Mar 03 2021 | ACRS | Aclaris Therapeuti ... | Walker Neal | President and CEO | Option Exercise | A | 24.06 | 255,800 | 6,154,548 | 255,800 | |
| Mar 03 2021 | ACRS | Aclaris Therapeuti ... | Walker Neal | President and CEO | Payment of Exercise | F | 23.25 | 7,982 | 185,582 | 1,222,427 | 1.2 M to 1.2 M (-0.65 %) |
| Mar 03 2021 | ACRS | Aclaris Therapeuti ... | Walker Neal | President and CEO | Buy | M | 0.00 | 18,253 | 0 | 1,230,409 | 1.2 M to 1.2 M (+1.51 %) |
| Mar 03 2021 | ACRS | Aclaris Therapeuti ... | Walker Neal | President and CEO | Payment of Exercise | F | 24.06 | 39,792 | 957,396 | 1,212,156 | 1.3 M to 1.2 M (-3.18 %) |
| Mar 03 2021 | ACRS | Aclaris Therapeuti ... | Walker Neal | President and CEO | Buy | M | 0.00 | 96,150 | 0 | 1,251,948 | 1.2 M to 1.3 M (+8.32 %) |
| Feb 03 2021 | ACRS | Aclaris Therapeuti ... | Mehra Anand | Director | Option Exercise | M | 18.32 | 6,632 | 121,498 | 0 | |
| Feb 03 2021 | ACRS | Aclaris Therapeuti ... | Mehra Anand | Director | Option Exercise | M | 18.35 | 8,000 | 146,800 | 0 | |
| Feb 03 2021 | ACRS | Aclaris Therapeuti ... | Mehra Anand | Director | Buy | M | 18.32 | 6,632 | 121,498 | 30,841 | 24.2 K to 30.8 K (+27.39 %) |
| Feb 03 2021 | ACRS | Aclaris Therapeuti ... | Mehra Anand | Director | Buy | M | 18.35 | 8,000 | 146,800 | 24,209 | 16.2 K to 24.2 K (+49.36 %) |
| Feb 03 2021 | ACRS | Aclaris Therapeuti ... | Ruffo Frank | Chief Financial Off ... | Option Exercise | M | 0.00 | 3,875 | 0 | 3,875 | |
| Feb 03 2021 | ACRS | Aclaris Therapeuti ... | Ruffo Frank | Chief Financial Off ... | Payment of Exercise | F | 21.35 | 1,308 | 27,926 | 215,189 | 216.5 K to 215.2 K (-0.60 %) |
| Feb 03 2021 | ACRS | Aclaris Therapeuti ... | Ruffo Frank | Chief Financial Off ... | Buy | M | 0.00 | 3,875 | 0 | 216,497 | 212.6 K to 216.5 K (+1.82 %) |
| Feb 03 2021 | ACRS | Aclaris Therapeuti ... | Ali-Jackson Kamil | Chief Legal Officer | Option Exercise | M | 0.00 | 3,875 | 0 | 3,875 | |
| Feb 03 2021 | ACRS | Aclaris Therapeuti ... | Ali-Jackson Kamil | Chief Legal Officer | Payment of Exercise | F | 21.35 | 1,318 | 28,139 | 126,646 | 128 K to 126.6 K (-1.03 %) |
| Feb 03 2021 | ACRS | Aclaris Therapeuti ... | Ali-Jackson Kamil | Chief Legal Officer | Buy | M | 0.00 | 3,875 | 0 | 127,964 | 124.1 K to 128 K (+3.12 %) |
| Feb 03 2021 | ACRS | Aclaris Therapeuti ... | Walker Neal | President and CEO | Option Exercise | M | 0.00 | 10,800 | 0 | 10,800 | |
| Feb 03 2021 | ACRS | Aclaris Therapeuti ... | Walker Neal | President and CEO | Payment of Exercise | F | 21.35 | 3,316 | 70,797 | 1,155,798 | 1.2 M to 1.2 M (-0.29 %) |
| Feb 03 2021 | ACRS | Aclaris Therapeuti ... | Walker Neal | President and CEO | Buy | M | 0.00 | 10,800 | 0 | 1,159,114 | 1.1 M to 1.2 M (+0.94 %) |
| Dec 17 2020 | ACRS | Aclaris Therapeuti ... | Walker Neal | President and CEO | Option Exercise | M | 0.00 | 3,034 | 0 | 0 | |
| Dec 17 2020 | ACRS | Aclaris Therapeuti ... | Walker Neal | President and CEO | Payment of Exercise | F | 4.59 | 871 | 3,998 | 1,148,314 | 1.1 M to 1.1 M (-0.08 %) |
| Dec 17 2020 | ACRS | Aclaris Therapeuti ... | Walker Neal | President and CEO | Buy | M | 0.00 | 3,034 | 0 | 1,149,185 | 1.1 M to 1.1 M (+0.26 %) |
| Dec 17 2020 | ACRS | Aclaris Therapeuti ... | Ruffo Frank | Chief Financial Off ... | Option Exercise | M | 0.00 | 1,300 | 0 | 0 | |
| Dec 17 2020 | ACRS | Aclaris Therapeuti ... | Ruffo Frank | Chief Financial Off ... | Payment of Exercise | F | 4.59 | 370 | 1,698 | 212,622 | 213 K to 212.6 K (-0.17 %) |
| Dec 17 2020 | ACRS | Aclaris Therapeuti ... | Ruffo Frank | Chief Financial Off ... | Buy | M | 0.00 | 1,300 | 0 | 212,992 | 211.7 K to 213 K (+0.61 %) |
| Dec 17 2020 | ACRS | Aclaris Therapeuti ... | Ali-Jackson Kamil | Chief Legal Officer | Option Exercise | M | 0.00 | 1,734 | 0 | 0 | |
| Dec 17 2020 | ACRS | Aclaris Therapeuti ... | Ali-Jackson Kamil | Chief Legal Officer | Payment of Exercise | F | 4.59 | 498 | 2,286 | 124,089 | 124.6 K to 124.1 K (-0.40 %) |
| Dec 17 2020 | ACRS | Aclaris Therapeuti ... | Ali-Jackson Kamil | Chief Legal Officer | Buy | M | 0.00 | 1,734 | 0 | 124,587 | 122.9 K to 124.6 K (+1.41 %) |
| Sep 03 2020 | ACRS | Aclaris Therapeuti ... | Walker Neal | President and CEO | Option Exercise | M | 0.00 | 83,092 | 0 | 0 | |
| Sep 03 2020 | ACRS | Aclaris Therapeuti ... | Walker Neal | President and CEO | Option Exercise | A | 0.00 | 83,092 | 0 | 83,092 | |
| Sep 03 2020 | ACRS | Aclaris Therapeuti ... | Walker Neal | President and CEO | Payment of Exercise | F | 2.33 | 23,872 | 55,622 | 1,146,151 | 1.2 M to 1.1 M (-2.04 %) |
| Sep 03 2020 | ACRS | Aclaris Therapeuti ... | Walker Neal | President and CEO | Buy | M | 0.00 | 83,092 | 0 | 1,170,023 | 1.1 M to 1.2 M (+7.64 %) |
| Jul 07 2020 | ACRS | Aclaris Therapeuti ... | Gordon David N. | Chief Medical Offic ... | Option Exercise | M | 0.00 | 6,000 | 0 | 12,000 | |
| Jul 07 2020 | ACRS | Aclaris Therapeuti ... | Gordon David N. | Chief Medical Offic ... | Payment of Exercise | F | 1.50 | 1,360 | 2,040 | 87,535 | 88.9 K to 87.5 K (-1.53 %) |
| Jul 07 2020 | ACRS | Aclaris Therapeuti ... | Gordon David N. | Chief Medical Offic ... | Buy | M | 0.00 | 6,000 | 0 | 88,895 | 82.9 K to 88.9 K (+7.24 %) |
| Jun 08 2020 | ACRS | Aclaris Therapeuti ... | Reasons Bryan M. | Director | Option Exercise | M | 0.00 | 7,333 | 0 | 0 | |
| Jun 08 2020 | ACRS | Aclaris Therapeuti ... | Reasons Bryan M. | Director | Option Exercise | A | 1.41 | 16,500 | 23,265 | 16,500 | |
| Jun 08 2020 | ACRS | Aclaris Therapeuti ... | Reasons Bryan M. | Director | Buy | M | 0.00 | 7,333 | 0 | 16,209 | 8.9 K to 16.2 K (+82.62 %) |
| Jun 08 2020 | ACRS | Aclaris Therapeuti ... | GOWEN MAXINE | Director | Option Exercise | A | 1.41 | 16,500 | 23,265 | 16,500 | |
| Jun 08 2020 | ACRS | Aclaris Therapeuti ... | Molineaux Christopher P. | Director | Option Exercise | M | 0.00 | 7,333 | 0 | 0 | |
| Jun 08 2020 | ACRS | Aclaris Therapeuti ... | Molineaux Christopher P. | Director | Option Exercise | A | 1.41 | 16,500 | 23,265 | 16,500 | |
| Jun 08 2020 | ACRS | Aclaris Therapeuti ... | Molineaux Christopher P. | Director | Buy | M | 0.00 | 7,333 | 0 | 23,891 | 16.6 K to 23.9 K (+44.29 %) |
| Jun 08 2020 | ACRS | Aclaris Therapeuti ... | Mehra Anand | Director | Option Exercise | M | 0.00 | 7,333 | 0 | 0 | |
| Jun 08 2020 | ACRS | Aclaris Therapeuti ... | Mehra Anand | Director | Option Exercise | A | 1.41 | 16,500 | 23,265 | 16,500 | |
| Jun 08 2020 | ACRS | Aclaris Therapeuti ... | Mehra Anand | Director | Buy | M | 0.00 | 7,333 | 0 | 16,209 | 8.9 K to 16.2 K (+82.62 %) |
| Jun 08 2020 | ACRS | Aclaris Therapeuti ... | Humphries William D. | Director | Option Exercise | M | 0.00 | 7,333 | 0 | 0 | |
| Jun 08 2020 | ACRS | Aclaris Therapeuti ... | Humphries William D. | Director | Option Exercise | A | 1.41 | 16,500 | 23,265 | 16,500 | |
| Jun 08 2020 | ACRS | Aclaris Therapeuti ... | Humphries William D. | Director | Buy | M | 0.00 | 7,333 | 0 | 16,209 | 8.9 K to 16.2 K (+82.62 %) |
| Jun 08 2020 | ACRS | Aclaris Therapeuti ... | Powell Andrew Kenneth William | Director | Option Exercise | M | 0.00 | 7,333 | 0 | 0 | |
| Jun 08 2020 | ACRS | Aclaris Therapeuti ... | Powell Andrew Kenneth William | Director | Option Exercise | A | 1.41 | 16,500 | 23,265 | 16,500 | |
| Jun 08 2020 | ACRS | Aclaris Therapeuti ... | Powell Andrew Kenneth William | Director | Buy | M | 0.00 | 7,333 | 0 | 16,709 | 9.4 K to 16.7 K (+78.21 %) |
| Jun 08 2020 | ACRS | Aclaris Therapeuti ... | SCHIFF ANDREW N | Director | Option Exercise | M | 0.00 | 7,333 | 0 | 0 | |
| Jun 08 2020 | ACRS | Aclaris Therapeuti ... | SCHIFF ANDREW N | Director | Option Exercise | A | 1.41 | 16,500 | 23,265 | 16,500 | |
| Jun 08 2020 | ACRS | Aclaris Therapeuti ... | SCHIFF ANDREW N | Director | Buy | M | 0.00 | 7,333 | 0 | 16,209 | 8.9 K to 16.2 K (+82.62 %) |
| Jun 08 2020 | ACRS | Aclaris Therapeuti ... | MILANO VINCENT | Director | Option Exercise | A | 1.41 | 16,500 | 23,265 | 16,500 | |
| Jun 03 2020 | ACRS | Aclaris Therapeuti ... | Walker Neal | President and CEO | Option Exercise | M | 0.00 | 73,014 | 0 | 73,015 | |
| Jun 03 2020 | ACRS | Aclaris Therapeuti ... | Walker Neal | President and CEO | Payment of Exercise | F | 1.32 | 20,976 | 27,688 | 1,086,931 | 1.1 M to 1.1 M (-1.89 %) |
| Jun 03 2020 | ACRS | Aclaris Therapeuti ... | Walker Neal | President and CEO | Buy | M | 0.00 | 73,014 | 0 | 1,107,907 | 1 M to 1.1 M (+7.06 %) |
| Jun 03 2020 | ACRS | Aclaris Therapeuti ... | Walker Neal | President and CEO | Option Exercise | M | 0.00 | 73,014 | 0 | 73,015 | |
| Jun 03 2020 | ACRS | Aclaris Therapeuti ... | Walker Neal | President and CEO | Payment of Exercise | F | 1.32 | 20,976 | 27,688 | 1,086,931 | 1.1 M to 1.1 M (-1.89 %) |
| Jun 03 2020 | ACRS | Aclaris Therapeuti ... | Walker Neal | President and CEO | Buy | M | 0.00 | 73,014 | 0 | 1,107,907 | 1 M to 1.1 M (+7.06 %) |
| Jun 03 2020 | ACRS | Aclaris Therapeuti ... | Ruffo Frank | Chief Financial Off ... | Option Exercise | M | 0.00 | 33,188 | 0 | 33,189 | |
| Jun 03 2020 | ACRS | Aclaris Therapeuti ... | Ruffo Frank | Chief Financial Off ... | Payment of Exercise | F | 1.32 | 9,451 | 12,475 | 211,692 | 221.1 K to 211.7 K (-4.27 %) |
| Jun 03 2020 | ACRS | Aclaris Therapeuti ... | Ruffo Frank | Chief Financial Off ... | Buy | M | 0.00 | 33,188 | 0 | 221,143 | 188 K to 221.1 K (+17.66 %) |
| Jun 03 2020 | ACRS | Aclaris Therapeuti ... | Ruffo Frank | Chief Financial Off ... | Option Exercise | M | 0.00 | 33,188 | 0 | 33,189 | |
| Jun 03 2020 | ACRS | Aclaris Therapeuti ... | Ruffo Frank | Chief Financial Off ... | Payment of Exercise | F | 1.32 | 9,451 | 12,475 | 211,692 | 221.1 K to 211.7 K (-4.27 %) |
| Jun 03 2020 | ACRS | Aclaris Therapeuti ... | Ruffo Frank | Chief Financial Off ... | Buy | M | 0.00 | 33,188 | 0 | 221,143 | 188 K to 221.1 K (+17.66 %) |
| Jun 03 2020 | ACRS | Aclaris Therapeuti ... | Gordon David N. | Chief Medical Offic ... | Option Exercise | M | 0.00 | 87,500 | 0 | 87,500 | |
| Jun 03 2020 | ACRS | Aclaris Therapeuti ... | Gordon David N. | Chief Medical Offic ... | Payment of Exercise | F | 1.32 | 24,045 | 31,739 | 82,895 | 106.9 K to 82.9 K (-22.48 %) |
| Jun 03 2020 | ACRS | Aclaris Therapeuti ... | Gordon David N. | Chief Medical Offic ... | Buy | M | 0.00 | 87,500 | 0 | 106,940 | 19.4 K to 106.9 K (+450.10 %) |
| Jun 03 2020 | ACRS | Aclaris Therapeuti ... | Gordon David N. | Chief Medical Offic ... | Option Exercise | M | 0.00 | 87,500 | 0 | 87,500 | |
| Jun 03 2020 | ACRS | Aclaris Therapeuti ... | Gordon David N. | Chief Medical Offic ... | Payment of Exercise | F | 1.32 | 24,045 | 31,739 | 82,895 | 106.9 K to 82.9 K (-22.48 %) |
| Jun 03 2020 | ACRS | Aclaris Therapeuti ... | Gordon David N. | Chief Medical Offic ... | Buy | M | 0.00 | 87,500 | 0 | 106,940 | 19.4 K to 106.9 K (+450.10 %) |
| Jun 03 2020 | ACRS | Aclaris Therapeuti ... | Ali-Jackson Kamil | Chief Legal Officer | Option Exercise | M | 0.00 | 33,188 | 0 | 33,189 | |
| Jun 03 2020 | ACRS | Aclaris Therapeuti ... | Ali-Jackson Kamil | Chief Legal Officer | Payment of Exercise | F | 1.32 | 9,534 | 12,585 | 122,853 | 132.4 K to 122.9 K (-7.20 %) |
| Jun 03 2020 | ACRS | Aclaris Therapeuti ... | Ali-Jackson Kamil | Chief Legal Officer | Buy | M | 0.00 | 33,188 | 0 | 132,387 | 99.2 K to 132.4 K (+33.46 %) |
| Mar 04 2020 | ACRS | Aclaris Therapeuti ... | Walker Neal | President and CEO | Option Exercise | M | 0.00 | 52,564 | 0 | 0 | |
| Mar 04 2020 | ACRS | Aclaris Therapeuti ... | Walker Neal | President and CEO | Option Exercise | A | 0.00 | 52,564 | 0 | 52,564 | |
| Mar 04 2020 | ACRS | Aclaris Therapeuti ... | Walker Neal | President and CEO | Option Exercise | A | 0.00 | 73,015 | 0 | 73,015 | |
| Mar 04 2020 | ACRS | Aclaris Therapeuti ... | Walker Neal | President and CEO | Option Exercise | A | 0.00 | 146,029 | 0 | 146,029 | |
| Mar 04 2020 | ACRS | Aclaris Therapeuti ... | Walker Neal | President and CEO | Option Exercise | A | 1.26 | 255,552 | 321,996 | 255,552 | |
| Mar 04 2020 | ACRS | Aclaris Therapeuti ... | Walker Neal | President and CEO | Option Exercise | M | 0.00 | 96,150 | 0 | 288,450 | |
| Mar 04 2020 | ACRS | Aclaris Therapeuti ... | Walker Neal | President and CEO | Payment of Exercise | F | 1.26 | 15,101 | 19,027 | 1,034,893 | 1 M to 1 M (-1.44 %) |
| Mar 04 2020 | ACRS | Aclaris Therapeuti ... | Walker Neal | President and CEO | Buy | M | 0.00 | 52,564 | 0 | 1,049,994 | 997.4 K to 1 M (+5.27 %) |
| Mar 04 2020 | ACRS | Aclaris Therapeuti ... | Walker Neal | President and CEO | Payment of Exercise | F | 1.26 | 27,623 | 34,805 | 997,430 | 1 M to 997.4 K (-2.69 %) |
| Mar 04 2020 | ACRS | Aclaris Therapeuti ... | Walker Neal | President and CEO | Buy | M | 0.00 | 96,150 | 0 | 1,025,053 | 928.9 K to 1 M (+10.35 %) |
| Mar 04 2020 | ACRS | Aclaris Therapeuti ... | SCHIFF ANDREW N | Director | Option Exercise | M | 0.00 | 8,876 | 0 | 0 | |
| Mar 04 2020 | ACRS | Aclaris Therapeuti ... | SCHIFF ANDREW N | Director | Option Exercise | A | 0.00 | 8,876 | 0 | 8,876 | |
| Mar 04 2020 | ACRS | Aclaris Therapeuti ... | SCHIFF ANDREW N | Director | Buy | M | 0.00 | 8,876 | 0 | 8,876 | 0 to 8.9 K |
| Mar 04 2020 | ACRS | Aclaris Therapeuti ... | Reasons Bryan M. | Director | Option Exercise | M | 0.00 | 8,876 | 0 | 0 | |
| Mar 04 2020 | ACRS | Aclaris Therapeuti ... | Reasons Bryan M. | Director | Option Exercise | A | 0.00 | 8,876 | 0 | 8,876 | |
| Mar 04 2020 | ACRS | Aclaris Therapeuti ... | Reasons Bryan M. | Director | Buy | M | 0.00 | 8,876 | 0 | 8,876 | 0 to 8.9 K |